ZLAB - CIK 0001704292
Zai Lab Ltd trades as ZLAB and has a market capitalization of $2.00 B, making it the #2098 largest US-listed company by market value. In its fiscal 2025 annual report the company posted revenue of $457.18M, up 15.0% from the prior year and net income of -$175.50M. This page tracks Zai Lab Ltd through 700 SEC filings, with financial statements and metrics updated as new reports are filed.
Over the last 7 fiscal years Zai Lab Ltd's revenue grew from $129.00K to $457.18M, a compound annual growth rate of 221.4%. Net profit margin expanded from -107810.1% to -38.4% over the same period - every figure below comes from the company's audited annual filings.
| Filing | Type | Filed |
|---|---|---|
| Major company event | 8-K | 2026-05-21 |
| Insider trade | 4 | 2026-05-21 |
| Insider trade | 4 | 2026-05-19 |
| Insider sale notice | 144 | 2026-05-18 |
| Insider sale notice | 144 | 2026-05-15 |
| Insider trade | 4 | 2026-05-15 |
| Insider trade | 4 | 2026-05-15 |
| Insider sale notice | 144 | 2026-05-14 |
The largest companies sharing Zai Lab Ltd's SEC industry classification (pharmaceutical preparations).
Zai Lab Ltd (ZLAB) has a market capitalization of $2.00 B as of 2026-05-29, ranking #2098 among US-listed companies.
Zai Lab Ltd reported revenue of $457.18M for fiscal year 2025, an increase of 15.0% year over year.
In its latest fiscal year Zai Lab Ltd reported a net loss of $175.50M.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
Dig into the full income statement, balance sheet, and cash flow statement with annual and quarterly views.